Insider Selling: Addus HomeCare (NASDAQ:ADUS) Insider Sells $27,005.76 in Stock

Addus HomeCare Corporation (NASDAQ:ADUS) insider Heather Brianne Dixon sold 288 shares of the firm’s stock in a transaction that occurred on Monday, June 22nd. The stock was sold at an average price of $93.77, for a total value of $27,005.76. Following the transaction, the insider owned 44,371 shares in the company, valued at approximately $4,160,668.67. The trade was a 0.64% decrease in their ownership of the stock. The transaction was disclosed in a legal filing with the Securities & Exchange Commission, which is available through the SEC website. The transaction was executed under a pre-arranged Rule 10b5-1 trading plan.

Addus HomeCare Trading Up 1.1%

NASDAQ:ADUS traded up $1.03 during midday trading on Tuesday, reaching $96.06. 221,869 shares of the stock traded hands, compared to its average volume of 241,073. The stock has a market capitalization of $1.79 billion, a P/E ratio of 17.76, a PEG ratio of 1.29 and a beta of 0.89. The company has a debt-to-equity ratio of 0.08, a quick ratio of 1.83 and a current ratio of 1.83. The company has a fifty day moving average of $93.97 and a 200 day moving average of $102.12. Addus HomeCare Corporation has a 12 month low of $87.95 and a 12 month high of $124.43.

Addus HomeCare (NASDAQ:ADUS) last announced its quarterly earnings results on Monday, May 4th. The company reported $1.62 earnings per share (EPS) for the quarter, topping analysts’ consensus estimates of $1.52 by $0.10. Addus HomeCare had a net margin of 6.89% and a return on equity of 9.80%. The business had revenue of $363.50 million for the quarter, compared to analyst estimates of $366.41 million. During the same quarter last year, the firm earned $1.42 EPS. The company’s revenue was up 7.7% on a year-over-year basis. On average, research analysts predict that Addus HomeCare Corporation will post 6.24 EPS for the current year.

Analyst Upgrades and Downgrades

Several equities analysts have recently issued reports on the company. Stephens reduced their target price on Addus HomeCare from $140.00 to $135.00 and set an “overweight” rating on the stock in a research note on Wednesday, February 25th. Citizens Jmp reaffirmed a “market outperform” rating and issued a $142.00 price target on shares of Addus HomeCare in a research note on Monday, May 18th. Wall Street Zen cut shares of Addus HomeCare from a “strong-buy” rating to a “buy” rating in a report on Saturday, March 21st. KeyCorp reissued an “overweight” rating on shares of Addus HomeCare in a research report on Wednesday, February 25th. Finally, Barclays dropped their target price on shares of Addus HomeCare from $102.00 to $92.00 and set an “underweight” rating for the company in a research report on Friday, May 15th. One analyst has rated the stock with a Strong Buy rating, six have assigned a Buy rating, two have assigned a Hold rating and one has given a Sell rating to the company. According to data from MarketBeat, Addus HomeCare has an average rating of “Moderate Buy” and a consensus target price of $131.00.

Institutional Trading of Addus HomeCare

A number of institutional investors and hedge funds have recently bought and sold shares of ADUS. Parallel Advisors LLC raised its holdings in Addus HomeCare by 66.3% in the first quarter. Parallel Advisors LLC now owns 404 shares of the company’s stock worth $38,000 after buying an additional 161 shares during the last quarter. Argent Capital Management LLC increased its position in shares of Addus HomeCare by 56.4% during the first quarter. Argent Capital Management LLC now owns 70,235 shares of the company’s stock valued at $6,578,000 after acquiring an additional 25,315 shares in the last quarter. Bank of America Corp DE increased its position in shares of Addus HomeCare by 11.3% during the first quarter. Bank of America Corp DE now owns 323,037 shares of the company’s stock valued at $30,252,000 after acquiring an additional 32,714 shares in the last quarter. Smith Group Asset Management LLC raised its holdings in Addus HomeCare by 10.0% in the 1st quarter. Smith Group Asset Management LLC now owns 5,760 shares of the company’s stock worth $539,000 after acquiring an additional 525 shares during the last quarter. Finally, Amundi raised its holdings in Addus HomeCare by 13.8% in the 1st quarter. Amundi now owns 2,868 shares of the company’s stock worth $269,000 after acquiring an additional 347 shares during the last quarter. 95.35% of the stock is currently owned by institutional investors.

About Addus HomeCare

Addus HomeCare (NASDAQ: ADUS) is a leading provider of home and community-based care services for elderly, disabled, and medically complex individuals across the United States. Through a network of company-owned and franchise locations, the company delivers a broad spectrum of non-medical personal care and licensed home health services designed to support clients’ independence and quality of life.

The company’s core offerings include personal care assistance—covering daily living activities, medication reminders, and light housekeeping—and skilled home health services delivered under the supervision of registered nurses and licensed therapists.